The novel NF-κB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-thy1.1-induced glomerulonephritis in rats

Nephron - Experimental Nephrology

Volumn 110, Issue 1, 2008, Pages

  Kosaka, Takeo ^a   Miyajima, Akira ^a   Kikuchi, Eiji ^a   Horiguchi, Yutaka ^b   Umezawa, Kazuo ^a   Ohigashi, Takashi ^a   Nakashima, Jun ^a   Asano, Tomohiko ^c   Oya, Mototsugu ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Apoptosis; Crescent formation; Leukocyte migration; Nuclear factor B; Proliferating cell nuclear antigen; Thy 1 model

Indexed keywords

CD45 ANTIGEN; CYCLINE; DEHYDROXYMETHYLEPOXYQUINOMICIN; FIBRONECTIN; I KAPPA B KINASE INHIBITOR; ANTIBODY; BENZAMIDE DERIVATIVE; CYCLOHEXANONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THY 1 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE CLEARANCE; GEL MOBILITY SHIFT ASSAY; GLOMERULONEPHRITIS; GLOMERULOPATHY; IMMUNOHISTOCHEMISTRY; MESANGIUM CELL; NICK END LABELING; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEINURIA; RAT; TRICHOME; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; GLOMERULUS; IMMUNOLOGY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PATHOLOGY;

ANIMALS; ANTIBODIES; ANTIGENS, THY-1; BENZAMIDES; CELL PROLIFERATION; CYCLOHEXANONES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; KIDNEY GLOMERULUS; NF-KAPPA B; RATS;

EID: 48649096672     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000150314     Document Type: Article

References (28)

1. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994;12:141-179.
2. Barkett M, Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999;18:6910-6924.
3. Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
4. Sakurai H, Hisada Y, Ueno M, Sugiura M, Kawashima K, Sugita T: Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim Biophys Acta 1996;1316:132-138.
5. Baldwin AS Jr: Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001;107:3-6.
6. Kim JH, Ha IS, Hwang CI, Lee YJ, Kim J, Yang SH, et al: Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappaB in immune complex kidney disease. Kidney Int 2004;66:1826-1837.
7. Lai PC, Smith J, Bhangal G, Chaudhry KA, Chaudhry AN, Keith JC Jr, et al: Interleukin-11 reduces renal injury and glomerular NF-kappa B activity in murine experimental glomerulonephritis. Nephron Exp Nephrol 2005;101:e146-e154.
8. Yamamoto T, Yamamoto K, Kawasaki K, Yaoita E, Shimizu F, Kihara I: Immunoelectron microscopic demonstration of Thy-1 antigen on the surfaces of mesangial cells in the rat glomerulus. Nephron 1986;43:293-298.
9. Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest 1986;55:680-687.
10. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 1995;47:114-121.
11. Tomita N, Morishita R, Lan HY, Yamamoto K, Hashizume M, Notake M, et al: In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000;11:1244-1252.
12. Hirahashi J, Takayanagi A, Hishikawa K, Takase O, Chikaraishi A, Hayashi M, et al: Overexpression of truncated I kappa B alpha potentiates TNF-alpha-induced apoptosis in mesangial cells. Kidney Int 2000;57:959-968.
13. Umezawa K, Ariga A, Matsumoto N: Naturally occurring and synthetic inhibitors of NF-kappaB functions. Anticancer Drug Des 2000;15:239-244.
14. Matsumoto N, Ariga A, To-e S, Nakamura H, Agata N, Hirano S, et al: Synthesis of NF-kappaB activation inhibitors derived from epoxyquinomicin C. Bioorg Med Chem Lett 2000;10:865-869.
15. Ariga A, Namekawa JI, Matsumoto N, Inoue JI, Umezawa K: Inhibition of TNF-alpha-induced nuclear translocation and activation of NF-kappa B by dehydroxymethyl-epoxyquinomicin. J Biol Chem 2002;277:24625-24630.
16. Umezawa K, Chaicharoenpong C: Molecular design and biological activities of NF-kappaB inhibitors. Mol Cells 2002;14:163-167.
17. Miyajima A, Kosaka T, Seta K, Asano T, Umezawa K, Hayakawa M: Novel nuclear factor kappa B activation inhibitor prevents inflammatory injury in unilateral ureteral obstruction. J Urol 2003;169:1559-1563.
18. Hochberg D, Johnson CW, Chen J, Cohen D, Stern J, Vaughan ED Jr, et al: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest 2000;80:1721-1728.
19. Morrissey JJ, Klahr S: Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int 1997;52:926-933.
20. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, et al: Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000;58:2301-2313.
21. Yamamoto Y, Gaynor RB: Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-142.
22. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M: Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995;270:286-290.
23. Sigal LJ, Crotty S, Andino R, Rock KL: Cytotoxic T-cell immunity to virus-infected nonhaematopoietic cells requires presentation of exogenous antigen. Nature 1999;398:77-80.
24. Ohsugi T, Kumasaka T, Ishida A, Ishida T, Horie R, Watanabe T, et al: In vitro and in vivo antitumor activity of the NF-kappaB inhibitor DHMEQ in the human T-cell leukemia virus type I-infected cell line, HUT-102. Leuk Res 2006;30:90-97.
25. Kikuchi E, Horiguchi Y, Nakashima J, Kuroda K, Oya M, Ohigashi T, et al: Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. Cancer Res 2003;63:107-110.
26. Kuroda K, Horiguchi Y, Nakashima J, Kikuchi E, Kanao K, Miyajima A, et al: Prevention of cancer cachexia by a novel nuclear factor kappa B inhibitor in prostate cancer. Clin Cancer Res 2005;11:5590-5594.
27. Schreiner GF: The role of the macrophage in glomerular injury. Semin Nephrol 1991;11:268-275.
28. Maruyama K, Kashihara N, Yamasaki Y, Sato M, Sugiyama H, Okamoto K, et al: Methylprednisolone accelerates the resolution of glomerulonephritis by sensitizing mesangial cells to apoptosis. Exp Nephrol 2001;9:317-326.